| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| neovastat | matrix metalloproteinase-12 | NA | Clinical trial target | TTD | Non-Small Cell Lung Carcinoma[MeSHID:D002289] Renal Cell Carcinoma[MeSHID:D002292] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | phase 1 | unknown |
| neovastat | matrix metalloproteinase-2 | NA | Successful target | TTD | Non-Small Cell Lung Carcinoma[MeSHID:D002289] Renal Cell Carcinoma[MeSHID:D002292] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | phase 1 | unknown |
| neovastat | matrix metalloproteinase-9 | NA | Clinical trial target | TTD | Non-Small Cell Lung Carcinoma[MeSHID:D002289] Renal Cell Carcinoma[MeSHID:D002292] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | phase 1 | unknown |
| click here to return to the previous page | ||||||||